DC Healthcare Holdings Berhad (KLSE:DCHCARE)
Malaysia · Delayed Price · Currency is MYR 0.1000
-0.0100 (-9.09%)
At close: Aug 11, 2026
KLSE:DCHCARE Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 100 | 115 | 174 | 404 | - | - | |
Market Cap Growth | -23.08% | -34.29% | -56.79% | - | - | - |
Enterprise Value | 116 | 123 | 180 | 384 | - | - |
Last Close Price | 0.10 | 0.12 | 0.17 | 0.41 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 90.42 | 556.90 | - | 161.14 | - | - |
PS Ratio | 1.10 | 1.32 | 3.13 | 5.96 | - | - |
PB Ratio | 2.21 | 2.55 | 3.90 | 6.27 | - | - |
P/TBV Ratio | 2.21 | 2.55 | 3.90 | 6.27 | - | - |
P/FCF Ratio | 113.50 | 187.28 | - | - | - | - |
P/OCF Ratio | 6.04 | 6.95 | 18.67 | 103.22 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.29 | 1.41 | 3.23 | 5.67 | - | - |
EV/EBITDA Ratio | 6.51 | 13.02 | - | 46.33 | - | - |
EV/EBIT Ratio | 25.23 | 36.80 | - | 61.37 | - | - |
EV/FCF Ratio | 132.62 | 200.76 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.92 | 0.99 | 0.87 | 0.36 | 1.60 | 2.22 |
Debt / EBITDA Ratio | 2.32 | 2.65 | - | 1.70 | 1.34 | 2.02 |
Debt / FCF Ratio | 47.18 | 72.60 | - | - | 4.82 | 2.37 |
Net Debt / Equity Ratio | 0.37 | 0.41 | 0.25 | -0.20 | 0.99 | 0.85 |
Net Debt / EBITDA Ratio | 1.57 | 1.95 | -0.81 | -1.54 | 1.03 | 0.99 |
Net Debt / FCF Ratio | 19.11 | 30.02 | -3.11 | 1.03 | 2.97 | 0.91 |
Asset Turnover | 0.83 | 0.78 | 0.54 | 0.92 | 1.29 | 1.03 |
Inventory Turnover | 12.44 | 10.94 | 9.71 | 10.40 | 16.66 | 14.43 |
Quick Ratio | 0.92 | 0.74 | 0.79 | 2.26 | 0.66 | 1.02 |
Current Ratio | 1.01 | 0.97 | 1.00 | 2.80 | 1.01 | 1.19 |
Return on Equity (ROE) | 2.61% | 0.46% | -36.01% | 6.30% | 82.96% | 72.18% |
Return on Assets (ROA) | 2.63% | 1.87% | -11.43% | 5.30% | 20.79% | 16.65% |
Return on Invested Capital (ROIC) | 3.06% | 0.70% | -35.16% | 7.74% | 45.66% | 40.06% |
Return on Capital Employed (ROCE) | 6.00% | 4.20% | -26.40% | 7.50% | 40.20% | 30.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.17% | 0.18% | -11.27% | 0.62% | - | - |
FCF Yield | 0.88% | 0.53% | -2.07% | -3.07% | - | - |
Payout Ratio | - | - | - | - | 31.39% | 54.32% |
Buyback Yield / Dilution | - | - | -12.10% | -11.51% | 20.00% | - |